Notably, in melanoma, a cancer type where LACTB is significantly downregulated and associated with poorer patient outcomes, restoring LACTB expression has emerged as a promising therapeutic approach due to its role in inducing apoptosis and modulating tumor growth [22,23]. The gene discussed is LACTB; the disease is melanoma.